Hyperferritinemia Causes and Diagnosis

Primary Causes

• The most common causes of hyperferritinemia include chronic alcohol consumption, inflammation, cell necrosis, tumors, and non-alcoholic fatty liver disease (NAFLD)/metabolic syndrome, which account for over 90% of cases in outpatients 1
• Non-HFE hemochromatosis (mutations in TFR2, SLC40A1, HAMP, HJV genes) is a cause of hyperferritinemia 1
• HFE gene mutations (C282Y homozygosity, C282Y/H63D compound heterozygosity) are associated with hereditary hemochromatosis (HH) 2

Secondary Causes

• Alcoholic liver disease is a cause of hyperferritinemia 2
• Viral hepatitis (B and C) is a cause of hyperferritinemia 3
• Non-alcoholic fatty liver disease (NAFLD) is a cause of hyperferritinemia 2
• Acute hepatitis is a cause of hyperferritinemia 4
• Systemic inflammatory response syndrome is a cause of hyperferritinemia 2
• Adult-onset Still's disease (AOSD) is a cause of hyperferritinemia 4
• Solid tumors are a cause of hyperferritinemia 1
• Lymphomas are a cause of hyperferritinemia 2
• Infections are a cause of hyperferritinemia 1
• Metabolic syndrome is a cause of hyperferritinemia 1
• Cell necrosis is a cause of hyperferritinemia 1

Diagnostic Approach

• The initial assessment of hyperferritinemia includes checking transferrin saturation (TS) and serum ferritin 1
• If TS ≥45% or elevated ferritin, proceed with further evaluation 2
• Rule out common causes of hyperferritinemia, including inflammation, cell necrosis, chronic alcohol consumption, metabolic syndrome, and tumors 1
• Perform HFE genetic testing for C282Y and H63D mutations if common causes are excluded 2
• Consider liver biopsy or MRI for hepatic iron concentration assessment if needed 3
• Consider testing for non-HFE hemochromatosis genes if iron overload is confirmed but C282Y homozygosity is excluded 1

Important Clinical Pearls

• Serum ferritin has high sensitivity but low specificity for iron overload, as it can be elevated in many inflammatory conditions 3
• In the general population, iron overload is not the most common cause of elevated ferritin 2
• A serum ferritin <1000 μg/L has a high negative predictive value for cirrhosis in hemochromatosis patients 2
• A serum ferritin >1000 μg/L with elevated liver enzymes and platelet count <200 predicts cirrhosis in 80% of C282Y homozygotes 2
• Glycosylated ferritin ≤20% has been used as a diagnostic marker for adult-onset Still's disease 4

Elevated Ferritin Levels: Diagnostic Considerations

Introduction to Ferritin as a Biomarker

• Ferritin is an acute phase reactant that rises during inflammation, and at a level of 377 ng/mL, it falls below the thresholds associated with significant iron overload complications (>1000 ng/mL for liver damage risk, >7500 ng/mL for documented organ damage) 5

Common Causes of Elevated Ferritin

• Active infection can cause ferritin to rise as part of the acute phase response, and it is essential to investigate for active infection as a cause of the elevated ferritin 5, 6, 7

Diagnostic Algorithm

• The American Journal of Kidney Diseases recommends checking transferrin saturation (TS) simultaneously with ferritin, and if TS <45%, iron overload is unlikely and secondary causes predominate 5, 6, 7
• The distinction between functional iron deficiency and inflammatory iron block is crucial, and in inflammatory states, ferritin rises acutely while transferrin saturation often drops, creating a pattern of elevated ferritin with low TS 5, 6, 7, 8

Clinical Implications

• Elevated ferritin at 377 ng/mL does not indicate risk of organ damage (threshold >1000 ng/mL) 5
• The association between elevated ferritin and infections is bidirectional, and infection causes ferritin to rise, not the other way around 5, 6, 7

Differential Diagnosis of Elevated Ferritin

Primary Diagnostic Framework

• Elevated ferritin has over 90% likelihood of being caused by non-iron overload conditions including chronic alcohol consumption, inflammation, cell necrosis, tumors, and metabolic syndrome/NAFLD—not hereditary hemochromatosis 9

Algorithmic Approach Based on Transferrin Saturation

• Hereditary hemochromatosis (HFE-related) is characterized by C282Y homozygosity or C282Y/H63D compound heterozygosity, according to the American Association for the Study of Liver Diseases 9, 10
• Non-HFE hemochromatosis is associated with mutations in TFR2, SLC40A1, HAMP, or HJV genes, as recommended by the European Association for the Study of the Liver 10
• Alcoholic liver disease and non-alcoholic fatty liver disease (NAFLD) are common causes of elevated ferritin, as stated by the American Gastroenterological Association 9, 10
• Hepatocellular carcinoma is a potential cause of elevated ferritin, according to the American Association for the Study of Liver Diseases 10

Risk Stratification by Ferritin Level

• Ferritin levels < 1000 μg/L are associated with low risk of organ damage, with a negative predictive value of 94% for advanced liver fibrosis in hemochromatosis, as reported by the National Institute of Diabetes and Digestive and Kidney Diseases 10
• Ferritin levels 1000-10,000 μg/L are associated with higher risk of advanced fibrosis/cirrhosis if iron overload is present, with a prevalence of cirrhosis in C282Y homozygotes of 20-45%, according to the American College of Gastroenterology 10

Complete Differential Diagnosis List

• Primary iron overload includes HFE hemochromatosis (C282Y homozygosity, C282Y/H63D compound heterozygosity) and non-HFE hemochromatosis (TFR2, SLC40A1, HAMP, HJV mutations), as diagnosed by the American College of Medical Genetics and Genomics 9, 10
• Liver disease includes chronic alcohol consumption, NAFLD/metabolic syndrome, and viral hepatitis B or C, as treated by the American Association for the Study of Liver Diseases 9, 10
• Inflammatory/rheumatologic conditions include adult-onset Still's disease, hemophagocytic lymphohistiocytosis, and systemic inflammatory response syndrome, as managed by the American College of Rheumatology 9, 11
• Malignancy includes solid tumors, lymphomas, and hepatocellular carcinoma, as diagnosed by the National Comprehensive Cancer Network 10
• Other conditions include chronic kidney disease, diabetes mellitus, and cell necrosis (muscle, liver), as treated by the American Diabetes Association and the National Kidney Foundation 9, 10

Critical Pitfalls to Avoid

• Never use ferritin alone without transferrin saturation to diagnose iron overload, as recommended by the American College of Physicians 9, 11
• Do not overlook liver biopsy in patients with ferritin >1000 μg/L and abnormal liver tests, as suggested by the American Association for the Study of Liver Diseases 10
• Do not assume iron overload when TS <45%, as stated by the European Association for the Study of the Liver 10
• Do not fail to screen first-degree relatives if HFE-related hemochromatosis is confirmed, as recommended by the American College of Medical Genetics and Genomics 10
• Recognize that extremely high ferritin (>10,000 μg/L) rarely represents simple iron overload, as reported by the American College of Emergency Physicians 10

Diagnostic Approach to Elevated Ferritin

Initial Evaluation

• The American Association for the Study of Liver Diseases recommends measuring both serum ferritin and transferrin saturation simultaneously to prevent diagnostic errors in evaluating hyperferritinemia 12, 13
• Initial laboratory tests should include fasting transferrin saturation, serum ferritin, complete blood count with differential, liver enzymes, and inflammatory markers 12, 13, 14

Differential Diagnosis

• Primary iron overload is possible when transferrin saturation is ≥45%, and HFE genetic testing for C282Y and H63D mutations should be considered 12, 13
• Hereditary hemochromatosis is diagnosed in C282Y homozygotes or C282Y/H63D compound heterozygotes 12, 13
• Secondary causes of hyperferritinemia, such as liver disease, inflammatory conditions, and malignancy, should be evaluated when transferrin saturation is <45% 13

Diagnostic Algorithm

• Ferritin levels <1,000 μg/L indicate low risk of organ damage, but therapeutic phlebotomy may be initiated in C282Y homozygotes with elevated transferrin saturation 12, 13
• Ferritin levels between 1,000-10,000 μg/L require additional evaluation, including platelet count and liver enzymes, and may indicate a high risk of cirrhosis in C282Y homozygotes 12, 13
• Ferritin levels >10,000 μg/L rarely represent simple iron overload and require urgent specialist referral to evaluate for life-threatening conditions 13

Special Population Considerations

• In patients with inflammatory bowel disease, ferritin levels <30 μg/L indicate iron deficiency, while levels >100 μg/L with low transferrin saturation suggest anemia of chronic disease 14
• In patients with chronic kidney disease, elevated ferritin with low transferrin saturation may still warrant IV iron therapy for anemia management, while high ferritin levels with high transferrin saturation may indicate liver cell damage 14

Investigating High Ferritin

Special Clinical Contexts

• In patients with chronic kidney disease and anemia, elevated ferritin (500-1200 μg/L) with low transferrin saturation (< 25%) may still warrant IV iron therapy, as shown in the DRIVE study where patients with ferritin 500-1200 μg/L and TS < 25% had significant hemoglobin improvement with IV iron (16 g/L vs 11 g/L, P=0.028) 15

Diagnostic Approach to Elevated Ferritin

Initial Evaluation

• The American Association for the Study of Liver Diseases recommends measuring fasting transferrin saturation (TS) alongside ferritin to diagnose iron overload, with a TS ≥45% indicating possible hereditary hemochromatosis or other primary iron overload disorders 16
• The European Association for the Study of the Liver suggests ordering a complete metabolic panel, including ALT and AST, to assess for hepatocellular injury in patients with elevated ferritin 17, 16
• Inflammatory markers such as CRP and ESR should be measured to detect occult inflammation, as recommended by the American College of Gastroenterology 16

Diagnostic Criteria

• The American College of Gastroenterology recommends HFE genetic testing for C282Y and H63D mutations in patients with TS ≥45%, as this indicates possible hereditary hemochromatosis or other primary iron overload disorders 16, 18, 19
• C282Y homozygotes with elevated iron stores are diagnosed with HFE hemochromatosis, according to the American Association for the Study of Liver Diseases 16, 20
• Therapeutic phlebotomy can begin without liver biopsy in patients with ferritin <1000 μg/L, normal liver enzymes, and age <40, as recommended by the European Association for the Study of the Liver 18, 20

Risk Stratification

• The American Association for the Study of Liver Diseases recommends risk stratification by ferritin level, with ferritin <1000 μg/L indicating low risk of organ damage, and ferritin >10,000 μg/L indicating a high risk of life-threatening conditions 16
• NAFLD patients with elevated ferritin do not automatically require iron overload evaluation unless TS is also elevated (>45%), according to the American College of Gastroenterology 17, 16

Management

• The American College of Gastroenterology recommends treating the underlying condition, not the elevated ferritin, in patients with secondary hyperferritinemia, such as weight loss and metabolic syndrome management for NAFLD patients 16
• The European Association for the Study of the Liver suggests disease-specific anti-inflammatory therapy for inflammatory conditions, and oncologic treatment for malignancy 16

Elevated Ferritin Levels: Diagnostic Approach and Management

Introduction to Ferritin Level Evaluation

• The American Journal of Kidney Diseases notes that active infection causes ferritin to rise acutely as part of the inflammatory response, and this association is bidirectional: infection causes elevated ferritin, not vice versa 21

Diagnostic Testing and Interpretation

• The Journal of Hepatology recommends fasting transferrin saturation (morning sample preferred, fasting not required) as part of the initial workup for elevated ferritin levels 22
• The Journal of Hepatology suggests considering liver MRI to quantify hepatic iron concentration if transferrin saturation is ≥45% 22
• The Journal of Hepatology recognizes that ferritin is an acute-phase reactant and can be elevated in many inflammatory conditions without true iron overload 22

Differential Diagnosis of Elevated Ferritin

Diagnostic Approach

• The American Journal of Kidney Diseases recommends distinguishing functional iron deficiency from inflammatory block in chronic kidney disease patients, as functional iron deficiency responds to IV iron, whereas inflammatory iron block does not 23
• Ferritin is an acute phase reactant that rises with inflammation, infection, and liver disease independent of iron stores, as noted by the American Journal of Kidney Diseases and the Journal of the American College of Cardiology 23, 24

Special Clinical Contexts

• The Journal of the American College of Cardiology indicates that iron deposition in myocardium can cause arrhythmias and cardiomyopathy, and ferritin >2,500 μg/L indicates increased risk of heart failure in β-thalassemia major 24
• The American Journal of Kidney Diseases suggests that functional iron deficiency can occur despite elevated ferritin when erythropoiesis is pharmacologically stimulated, and a trial approach with weekly IV iron can help distinguish it from inflammatory block 23

Diagnostic Approach to Elevated Ferritin Levels

Understanding Ferritin and Iron Overload

• The American Journal of Kidney Diseases recommends distinguishing functional iron deficiency from inflammatory iron block in patients with chronic kidney disease, with functional iron deficiency characterized by serial ferritin decreases during erythropoietin therapy but remaining >100 ng/mL 25
• In chronic kidney disease, absolute iron deficiency is defined as ferritin <100 ng/mL and TS <20%, according to the American Journal of Kidney Diseases 25
• Functional iron deficiency in CKD occurs with pharmacologic erythropoiesis stimulation, despite adequate iron stores, as noted by the American Journal of Kidney Diseases 25

Special Clinical Contexts

• In patients with chronic kidney disease, a trial of weekly IV iron (50-125 mg for 8-10 doses) can differentiate between functional iron deficiency and inflammatory block, with no response indicating inflammatory block, as suggested by the American Journal of Kidney Diseases 25

Elevated Ferritin with Normal Iron: Clinical Significance

Understanding the Paradox

• Ferritin is an acute-phase reactant that rises during inflammation independent of actual iron stores, and its elevation can indicate cellular damage or metabolic dysfunction, according to the European Society of Clinical Microbiology and Infectious Diseases 26, 27

Diagnostic Algorithm Based on Transferrin Saturation

• In inflammatory states, ferritin can be elevated while patients remain functionally iron deficient, as hepcidin blocks iron release from storage sites, and the American Gastroenterological Association recommends considering this condition in patients with inflammatory bowel disease 27
• The European Association for the Study of the Liver suggests that ferritin elevation reflects hepatocellular injury and insulin resistance rather than iron overload in patients with metabolic syndrome/NAFLD 26

Special Consideration: Functional Iron Deficiency

• The National Institute of Diabetes and Digestive and Kidney Diseases states that in chronic kidney disease, ferritin 100-700 ng/mL with TS <20% may represent functional iron deficiency that responds to IV iron therapy, and the Kidney Disease: Improving Global Outcomes guideline recommends evaluating iron status in these patients 27

Hyperferritinemia Diagnosis and Management

Inflammatory Conditions

• Adult-onset Still's disease (AOSD) is characterized by extreme hyperferritinemia (4,000-30,000 ng/mL, occasionally up to 250,000 ng/mL) with glycosylated ferritin fraction <20%, and serum ferritin correlates with disease activity and often normalizes with remission, according to the Annals of the Rheumatic Diseases 28
• Liver function tests, such as AST, ALT, and albumin, should be assessed to evaluate hepatocellular injury in patients with hyperferritinemia, as recommended by the Annals of the Rheumatic Diseases 28
• Glycosylated ferritin fraction <20% is 93% specific for AOSD when combined with 5-fold ferritin elevation, as reported by the Annals of the Rheumatic Diseases 28

Elevated Ferritin Causes and Diagnostic Approach

Introduction to Ferritin as a Biomarker

• Ferritin functions as an acute phase reactant, tumor marker, and indicator of cellular damage, rising during inflammation, infection, and tissue injury independent of actual iron levels, as noted by the European Association for the Study of the Liver 29

Primary Categories of Elevated Ferritin

Iron Overload Disorders

• Hereditary hemochromatosis (HFE-related) is characterized by C282Y homozygosity or C282Y/H63D compound heterozygosity, according to the European Association for the Study of the Liver 29

Liver Disease

• Chronic alcohol consumption increases iron absorption and causes hepatocellular injury, as reported by the European Association for the Study of the Liver 29
• Acute hepatitis and cirrhosis are associated with elevated ferritin levels, as noted by the European Association for the Study of the Liver 29

Inflammatory and Rheumatologic Conditions

• Chronic rheumatologic diseases are associated with elevated ferritin levels, as reported by the European Association for the Study of the Liver 29

Cellular Damage

• Cell necrosis from muscle injury, hepatocellular necrosis, or tissue breakdown is associated with elevated ferritin levels, as noted by the European Association for the Study of the Liver 29
• Ferritin is released from necrotic or lysed cells, according to the European Association for the Study of the Liver 29

Assessment of Alcohol Consumption

• A detailed history of alcohol consumption is necessary to evaluate its contribution to elevated ferritin levels, as reported by the European Association for the Study of the Liver 29

Diagnosis and Management of Elevated Ferritin

Introduction to Elevated Ferritin Diagnosis

• The American Association for the Study of Liver Diseases recommends measuring fasting transferrin saturation (TS) to distinguish between true iron overload and secondary causes of hyperferritinemia, followed by HFE genetic testing if TS ≥45% 30
• Measuring transferrin saturation is the single most important test to determine if iron overload is present, as ferritin alone cannot distinguish between true iron overload and secondary causes 30

Diagnostic Approach

• If TS ≥45%, suspect primary iron overload and proceed with HFE genetic testing for C282Y and H63D mutations to diagnose hereditary hemochromatosis 30
• C282Y homozygotes confirm HFE hemochromatosis and can proceed to therapeutic phlebotomy without liver biopsy since ferritin is >1000 µg/L 30
• Consider liver biopsy in patients with ferritin >1000 µg/L and abnormal liver tests, as this combination warrants histologic assessment for cirrhosis 30

Risk Stratification

• Ferritin >1000 µg/L with elevated ALT significantly increases the risk of advanced fibrosis or cirrhosis if iron overload is present 30
• The combination of ferritin >1000 µg/L, elevated aminotransferases, and platelet count <200 predicts cirrhosis in 80% of C282Y homozygotes 30

Critical Considerations

• Never use ferritin alone to diagnose iron overload, as ferritin is an acute phase reactant elevated in inflammation, liver disease, malignancy, and tissue necrosis independent of iron stores 30
• Do not assume iron overload when TS <45%, as in the general population, iron overload is NOT the most common cause of elevated ferritin 30
• Do not overlook liver biopsy in patients with ferritin >1000 µg/L and abnormal liver tests, as this combination warrants histologic assessment for cirrhosis 30

Management

• If hereditary hemochromatosis is confirmed (C282Y homozygote with TS ≥45%), initiate therapeutic phlebotomy and screen first-degree relatives 30

Diagnostic Approach to Elevated Ferritin

Initial Evaluation

• The American Association for the Study of Liver Diseases recommends measuring fasting transferrin saturation (TS) alongside ferritin, as over 90% of elevated ferritin cases are not due to iron overload, and TS ≥45% is the key discriminator for true iron overload requiring genetic testing 31
• The European Association for the Study of the Liver suggests ordering comprehensive metabolic panel including AST, ALT to assess hepatocellular injury 31
• The American College of Gastroenterology recommends evaluating inflammatory markers, such as CRP and ESR, to detect occult inflammation 31
• Creatine kinase (CK) should be checked to evaluate for muscle necrosis, as recommended by the American Association for Clinical Chemistry 31

Diagnostic Algorithm

• If TS ≥45%, suspect primary iron overload and order HFE genetic testing for C282Y and H63D mutations to diagnose hereditary hemochromatosis, as recommended by the American College of Medical Genetics 31
• C282Y homozygotes with elevated iron stores confirm HFE hemochromatosis and can proceed to therapeutic phlebotomy, according to the National Institute of Diabetes and Digestive and Kidney Diseases 31
• Liver biopsy should be offered to C282Y homozygotes with ferritin >1000 μg/L, elevated AST, hepatomegaly, or age >40 years, as suggested by the American Association for the Study of Liver Diseases 31

Special Considerations

• In patients with chronic kidney disease, elevated ferritin with low TS (<20%) may represent functional iron deficiency that responds to IV iron therapy, as recommended by the National Kidney Foundation 32
• In patients with inflammatory bowel disease, ferritin <30 μg/L indicates iron deficiency, and ferritin >100 μg/L with low TS suggests anemia of chronic disease, according to the Crohn's & Colitis Foundation 33

Elevated Ferritin with Normal Iron Levels: Clinical Significance

Diagnostic Approach

• Elevated ferritin with low transferrin saturation (<20%) indicates functional iron deficiency or inflammatory iron block, according to the American Journal of Hematology 34
• Soluble transferrin receptor (sTfR) testing can help distinguish true iron deficiency from inflammatory iron block, as it is elevated in true iron deficiency but not affected by inflammation, as reported by the American Journal of Hematology 34
• Reticulocyte hemoglobin content (CHr) or equivalent (RET-He) can be used for direct assessment of iron availability to erythropoiesis, as suggested by the American Journal of Hematology 34

Management Considerations

• The American Journal of Hematology recommends avoiding iron parameter checks within 4 weeks of IV iron administration, as circulating iron can interfere with assays and lead to spurious results 34

Elevated Ferritin Diagnosis and Management

Introduction to Elevated Ferritin

• The American Association for the Study of Liver Diseases recommends that a ferritin level >1000 μg/L is a critical threshold that changes management, with a prevalence of cirrhosis of 20-45% in C282Y homozygotes 35
• A ferritin level >1000 μg/L has 100% sensitivity but only 70% specificity for cirrhosis in hemochromatosis patients, according to the American College of Gastroenterology 35

Diagnostic Approach

• The European Association for the Study of the Liver suggests that liver biopsy should be considered if ferritin >1000 μg/L and elevated liver enzymes or platelet count <200,000/μL are present 35
• The American College of Physicians recommends that therapeutic phlebotomy can be initiated without biopsy in C282Y homozygous patients with normal liver enzymes and age <40 years 35

Evaluation of Elevated Ferritin

Initial Laboratory Panel

• The British Journal of Dermatology recommends ordering a complete blood count (CBC) with differential to assess for anemia, polycythemia, or hematologic malignancy in patients with elevated ferritin 36

Hematologic Causes Requiring Specific Evaluation

• The British Journal of Dermatology suggests looking for aquagenic pruritus, elevated hemoglobin/hematocrit, and ordering JAK2 mutation testing to evaluate for polycythemia vera in patients with elevated ferritin 36
• The British Journal of Dermatology recommends assessing for B symptoms, lymphadenopathy, and considering CT imaging if suspected to evaluate for lymphoma in patients with elevated ferritin 36
• The British Journal of Dermatology advises checking tissue transglutaminase (TTG) antibodies if unexplained iron deficiency coexists with elevated ferritin to evaluate for celiac disease 36

Diagnostic Approach to High Ferritin, Low TIBC, and Normal Iron

Introduction to Anemia of Chronic Disease

• The American Journal of Kidney Diseases recommends recognizing functional iron deficiency in chronic kidney disease as an exception, where ferritin 100-700 ng/mL with TSAT <20% may respond to IV iron therapy despite the elevated ferritin 37

Management of Underlying Conditions

• The American Journal of Kidney Diseases suggests that in CKD patients on erythropoiesis-stimulating agents, a trial of IV iron may be considered if TSAT <20% despite ferritin >100 ng/mL, with weekly IV iron 50-125 mg for 8-10 doses to distinguish functional iron deficiency from pure inflammatory block 37

Diagnosis and Management of Elevated Ferritin

Introduction to Ferritin Elevation

• Elevated CRP (5.4 mg/L, above the 5 mg/L threshold) is associated with inflammation and metabolic conditions, independent of actual iron stores, according to the Annals of the Rheumatic Diseases 38

Inflammatory and Systemic Causes

• ESR is an additional inflammatory marker that can be used to assess for infection, malignancy, or hematologic disorders, as noted in the Annals of the Rheumatic Diseases 39
• The combination of elevated CRP and ferritin is strongly suggestive of secondary hyperferritinemia from inflammation or metabolic causes, as supported by the Annals of the Rheumatic Diseases 38

Exclude Specific High-Risk Conditions

• If ferritin continues rising or exceeds 4,000-5,000 ng/mL with persistent fever, consider Adult-Onset Still's Disease and measure glycosylated ferritin fraction (<20% is 93% specific for AOSD), as recommended by the Annals of the Rheumatic Diseases 40, 38
• Screen for macrophage activation syndrome if clinical suspicion exists (persistent fever, splenomegaly, cytopenias, elevated triglycerides, abnormal liver function), according to the Annals of the Rheumatic Diseases 40, 38

Management of Inflammatory Iron Block

Understanding the Pathophysiology

• The pattern of low transferrin saturation (<20%) with elevated ferritin (>300 ng/mL) indicates anemia of chronic inflammation, where iron is sequestered in storage sites and unavailable for erythropoiesis, according to the American Journal of Hematology 41
• Hepcidin elevation in response to inflammatory cytokines (TNF-α, IL-6) blocks intestinal iron absorption and traps iron in reticuloendothelial macrophages, as reported by the American Journal of Hematology 41

Management Algorithm

• The American Journal of Hematology recommends not administering oral or IV iron unless specific exceptions apply, as iron supplementation will not improve anemia and may worsen outcomes by feeding bacterial infections, promoting oxidative stress, and failing to address the root cause 41
• In patients with congestive heart failure and iron deficiency, IV iron improves functional capacity and quality of life, even without anemia, with ferric carboxymaltose showing improved 6-minute walk distance, better Kansas City Cardiomyopathy Questionnaire scores, and reduced fatigue severity, as reported by the American Journal of Hematology 41

Iron Deficiency Management

Diagnosis and Treatment

• The American Journal of Kidney Diseases recommends oral iron supplementation with ferrous sulfate 300 mg three times daily for patients with low ferritin levels indicating iron deficiency, with intravenous iron reserved for those who cannot tolerate or absorb oral iron 42
• Absolute iron deficiency is defined as ferritin <100 ng/mL and TSAT <20%, according to the American Journal of Kidney Diseases 42
• The American Journal of Kidney Diseases suggests that ferritin alone is insufficient for diagnosis, as it is an acute phase reactant that rises with inflammation, infection, liver disease, and malignancy independent of iron stores 42
• The American Journal of Kidney Diseases recommends continuing oral iron supplementation for at least 3 months to replenish iron stores, not just until hemoglobin normalizes, and targeting ferritin levels of >100 ng/mL 42
• The American Journal of Kidney Diseases advises against supplementing iron when TSAT <20% with ferritin >300 ng/mL, as this represents anemia of chronic inflammation where iron is sequestered and supplementation will not improve anemia 42
• The American Journal of Kidney Diseases recommends measuring ferritin and TSAT after 3 months of treatment to assess iron store repletion, and continuing supplementation until ferritin reaches target levels 42
• The American Journal of Kidney Diseases suggests monitoring ferritin monthly during the induction phase of IV iron therapy, and targeting ferritin levels of ≥100 ng/mL and TSAT ≥20% in chronic kidney disease patients 42
• In chronic kidney disease patients with functional iron deficiency (ferritin 100-700 ng/mL with TSAT <20%), IV iron may still be beneficial despite elevated ferritin, according to the American Journal of Kidney Diseases 42

Diagnostic Approach to Elevated Ferritin with Normal TIBC and Serum Iron

Understanding the Clinical Pattern

• Normal TIBC suggests the iron-binding capacity is intact, which argues against severe iron overload, according to the American Journal of Kidney Diseases 43

Special Clinical Context: Chronic Kidney Disease

• In patients with chronic kidney disease on erythropoiesis-stimulating agents, elevated ferritin with low transferrin saturation may represent functional iron deficiency that responds to IV iron therapy, as demonstrated by the DRIVE study in Kidney International Supplements 44
• The Kidney International Supplements guidelines suggest that IV iron therapy can improve hemoglobin levels in CKD patients on ESAs with functional iron deficiency, with a significant hemoglobin improvement of 16 g/L vs 11 g/L (P=0.028) 44

Dietary Restrictions for Accurate Iron Studies

Pre-Test Requirements

• Patients should avoid all iron-containing supplements and foods for at least 24 hours prior to blood draw for serum ferritin and transferrin saturation testing, with the test ideally performed in the morning, as recommended by the American Academy of Sleep Medicine 45, 46, 47, 48
• The American Academy of Sleep Medicine suggests that testing should ideally be administered in the morning to ensure accurate results 45, 46, 47, 48

Rationale for Restrictions

• Dietary iron and supplements can acutely elevate serum iron levels, which directly affects transferrin saturation calculations, highlighting the importance of a 24-hour avoidance period before testing 45, 46, 47, 48
• Transferrin saturation is calculated from serum iron divided by total iron binding capacity, making it highly susceptible to recent iron intake, and thus requiring careful pre-test dietary restrictions 45, 46, 47, 48
• Accurate iron studies are essential for determining whether to use oral or intravenous iron treatment, particularly in conditions like restless legs syndrome where iron supplementation thresholds differ from the general population 45, 46, 47, 48

Foods and Supplements to Avoid

• The American Academy of Sleep Medicine recommends avoiding all iron supplements, iron-fortified foods and cereals, red meat, organ meats, shellfish, and other high-iron seafood for at least 24 hours before iron studies 45, 46, 47, 48

Clinical Context and Importance

• The analysis of iron studies greatly influences the decision to use oral or intravenous iron treatment, with different thresholds for supplementation depending on the clinical condition, such as restless legs syndrome where iron supplementation should be instituted with oral or IV iron if serum ferritin ≤75 ng/mL or transferrin saturation <20% 45, 47
• Recent iron intake can falsely elevate transferrin saturation, potentially leading to unnecessary genetic testing for hemochromatosis or inappropriate treatment decisions, emphasizing the need for strict pre-test dietary restrictions 45, 46, 47, 48

Management of Iron Deficiency

Immediate Treatment

• The American Journal of Kidney Diseases recommends initiating oral ferrous sulfate 300 mg three times daily immediately to replenish depleted iron stores, with a target ferritin level >100 ng/mL and transferrin saturation >20% 49
• Continue supplementation for at least 3 months to fully replenish stores, not just until hemoglobin normalizes, and recheck ferritin and transferrin saturation after 3 months of treatment 49

Critical Diagnostic Workup

• The Journal of Crohn's and Colitis suggests that a rapid ferritin decline indicates ongoing iron loss, and upper and lower endoscopy should be considered if occult blood positive or high clinical suspicion, particularly in adults >50 years or with GI symptoms 50

Special Considerations and Pitfalls

• The American Journal of Kidney Diseases recommends considering intravenous iron if oral iron fails after 3 months, and the Journal of Crohn's and Colitis suggests initiating IV iron immediately in patients with known or suspected IBD when ferritin drops below 100 μg/L 49, 50
• The Journal of Crohn's and Colitis notes that a rapid ferritin decline in an IBD patient may indicate subclinical disease activity even with normal inflammatory markers, and monthly ferritin monitoring is appropriate during the initial treatment phase if clinical concern is high 50, 49
• The American Journal of Kidney Diseases and the Journal of Crohn's and Colitis agree that ferritin must reach >100 ng/mL to ensure adequate iron stores, and premature discontinuation leads to rapid recurrence 49, 50

Evaluation and Management of Elevated Ferritin

Diagnostic Criteria

• Transferrin saturation ≥45% is required to suspect primary iron overload and proceed with HFE genetic testing, as recommended by the American Association for the Study of Liver Diseases 51, 52
• When TSAT is <45%, iron overload is unlikely and secondary causes predominate, with over 90% of elevated ferritin cases caused by inflammation, chronic alcohol consumption, cell necrosis, tumors, or metabolic syndrome/NAFLD 51, 53

Diagnostic Workup

• The combination of mildly elevated ferritin with elevated ALT and normal TSAT strongly suggests non-alcoholic fatty liver disease (NAFLD) or metabolic syndrome as the underlying cause, according to the American Association for the Study of Liver Diseases 51, 53
• Elevated ALT indicates active hepatocellular inflammation, as noted by the American Association for the Study of Liver Diseases 53

Management Strategy

• The treatment target is the underlying liver disease (likely NAFLD), not the elevated ferritin itself, as recommended by the American Association for the Study of Liver Diseases 51
• Phlebotomy is only indicated for confirmed iron overload with elevated transferrin saturation and evidence of end-organ damage, as stated by the American Association for the Study of Liver Diseases 51
• Liver biopsy should be considered if ferritin exceeds 1000 μg/L with abnormal liver tests, as recommended by the American Association for the Study of Liver Diseases 53, 52

Referral to Hepatology

• Refer to hepatology if ferritin rises above 1000 μg/L despite treatment, as recommended by the American Association for the Study of Liver Diseases 53, 52
• Refer to hepatology if transferrin saturation becomes elevated (≥45%) on repeat testing, as stated by the American Association for the Study of Liver Diseases 51

Diagnostic Approach to Elevated Ferritin and CRP

Introduction to Diagnostic Considerations

• The American College of Rheumatology suggests that adult-onset Still's disease should be considered if ferritin rises above 4,000-5,000 ng/mL with persistent fever, and measuring glycosylated ferritin fraction (<20% is 93% specific for AOSD) is recommended 54

Diagnostic Evaluation of Secondary Causes

• The National Comprehensive Cancer Network recommends that hemophagocytic lymphohistiocytosis/macrophage activation syndrome be considered if ferritin >5,000 ng/mL with cytopenias, fever, and multiorgan dysfunction 55

Liver Disease Considerations

• The Annals of the Rheumatic Diseases suggest that liver biopsy should be considered if age >40 years, elevated AST, hepatomegaly, or platelet count <200,000/μL, as the combination of ferritin >1,000 ng/mL with these features predicts cirrhosis in 80% of C282Y homozygotes 54

Elevated Ferritin Causes and Diagnosis

Primary Categories of Elevated Ferritin

• HFE-related hemochromatosis (C282Y homozygosity or C282Y/H63D compound heterozygosity) is present in >80% of patients with clinically overt hemochromatosis, according to the American Association for the Study of Liver Diseases 56
• Prevalence of C282Y homozygosity is highest among non-Hispanic white persons (0.44%), as reported by the American College of Medical Genetics 57

Secondary Causes of Elevated Ferritin

• Chronic alcohol consumption increases iron absorption and causes hepatocellular injury, leading to elevated ferritin levels, as stated by the American Association for the Study of Liver Diseases 56
• Non-alcoholic fatty liver disease (NAFLD)/metabolic syndrome causes ferritin elevation reflecting hepatocellular injury and insulin resistance rather than true iron overload, according to the American Association for the Study of Liver Diseases 56
• Chronic inflammatory diseases (rheumatoid arthritis, inflammatory bowel disease) elevate ferritin as an acute phase reactant, as reported by the American Association for the Study of Liver Diseases 56
• Cell necrosis from muscle injury, hepatocellular necrosis, or tissue breakdown releases ferritin from lysed cells, independent of iron stores, as stated by the American Association for the Study of Liver Diseases 56

Diagnostic Algorithm

• If transferrin saturation (TS) ≥45% with elevated ferritin, suspect primary iron overload and proceed immediately to HFE genotype testing for C282Y and H63D mutations, as recommended by the American Association for the Study of Liver Diseases 56
• Consider liver biopsy if ferritin >1,000 μg/L with elevated liver enzymes or platelet count <200,000/μL, as suggested by the American Association for the Study of Liver Diseases 56

Evaluation of Hyperferritinemia

Introduction to Hyperferritinemia Diagnosis

• The European Association for the Study of the Liver (EASL) and British Society of Gastroenterology guidelines recommend abdominal ultrasound as part of the standard initial workup for hyperferritinemia, regardless of transferrin saturation levels, to evaluate for underlying liver disease including fatty liver, chronic liver disease, and hepatomegaly 58
• Elevated ferritin with normal transferrin saturation (<45%) strongly suggests secondary causes rather than iron overload, according to the Journal of Hepatology 59, 58

Diagnostic Approach

• The 2018 Gut guidelines explicitly state that abdominal ultrasound should be included in the standard liver aetiology screen for adults with abnormal liver parameters, which applies to scenarios with elevated ferritin and normal transferrin saturation 58
• Ultrasound identifies the most common culprit, with nearly 40% of adults with abnormal liver tests having fatty liver on ultrasound, and obesity being more strongly associated with fatty liver than alcohol excess, as found in the BALLETS study 58
• If ultrasound shows fatty liver, diagnose NAFLD if alcohol consumption is not excessive, as recommended by the Gut and Gastroenterology guidelines 58, 60
• Assess for metabolic risk factors, including obesity, glucose intolerance, and dyslipidemia, in patients with NAFLD, as suggested by the Gut and Gastroenterology guidelines 58, 60

Interpretation of Ultrasound Findings

• Use non-invasive fibrosis scores (FIB-4 or NAFLD Fibrosis Score) to stratify risk in patients with NAFLD, as recommended by the Gut guidelines 58
• If ultrasound shows other abnormalities, such as hepatomegaly, cirrhotic features, or bile duct dilation, specialist referral is required, according to the Gut guidelines 58

When to Avoid Liver Biopsy

• You do NOT need liver biopsy or advanced imaging if ferritin <1,000 μg/L, which has a 94% negative predictive value for advanced fibrosis, as reported in the Journal of Hepatology 59
• This combination has a 94% negative predictive value for advanced liver fibrosis in patients with normal transferrin saturation, making liver biopsy unnecessary in such cases, according to the Journal of Hepatology 59, 61

Elevated Ferritin: Diagnostic Approach and Management

Understanding the Clinical Context

• Liver disease, such as NAFLD, alcoholic liver disease, or hepatocellular injury, can cause elevated ferritin, and checking ALT, AST, and considering abdominal ultrasound can help evaluate for these conditions, as recommended by the Gut society 62

Algorithmic Diagnostic Approach

Step 2: Evaluate for Secondary Causes (When TS <45%)

• No cited facts are available for this section.

Management Strategy

No cited facts are available for this section.

Diagnostic Approach to Elevated Ferritin

Initial Evaluation

• The British Journal of Dermatology recommends a complete blood count (CBC) with differential to evaluate for anemia, polycythemia, or hematologic malignancy in patients with elevated ferritin 63
• The British Journal of Dermatology suggests looking for aquagenic pruritus and ordering JAK2 mutation testing if polycythemia vera is suspected, and assessing for B symptoms and lymphadenopathy if lymphoma is suspected 63
• The Gastroenterology society recommends tissue transglutaminase (TTG) antibodies if unexplained iron deficiency coexists with elevated ferritin, with small bowel biopsy reserved for positive serologies requiring pathologic confirmation 64

Special Population Considerations

• The British Journal of Dermatology recommends serum protein electrophoresis (SPEP) if multiple myeloma is considered, though it is rarely associated with pruritus 63
• The Gastroenterology and British Journal of Dermatology societies suggest considering celiac disease screening with tissue transglutaminase (TTG) antibodies if unexplained iron deficiency coexists with elevated ferritin 63, 64

Causes of Falsely Low Ferritin Levels

Clinical Conditions and Laboratory Considerations

• The National Comprehensive Cancer Network (NCCN) notes that chronic inflammation may elevate serum ferritin in patients with cancer, even when iron deficiency is present 65, 66.
• In patients with true iron deficiency who also have inflammation, ferritin levels may be in the 30-100 ng/mL range, appearing normal but actually inappropriately low given the inflammatory state 65, 66, 67.
• Functional iron deficiency in chronic kidney disease (CKD) patients on erythropoiesis-stimulating agents may occur when ferritin remains in the 100-700 ng/mL range while transferrin saturation drops below 20%, indicating iron is sequestered and unavailable despite seemingly adequate ferritin levels 67.
• The American Journal of Kidney Diseases guidelines state that ferritin is an acute-phase reactant that can be elevated in CKD patients even when functional iron deficiency exists 67.
• The NKF-K/DOQI guidelines recommend measuring transferrin saturation simultaneously with ferritin to confirm true iron deficiency, defined as ferritin <100 ng/mL (or <30 ng/mL in some guidelines) with transferrin saturation <20% 65, 66, 67.
• The National Comprehensive Cancer Network (NCCN) guidelines suggest checking complete blood count with MCV to assess for microcytic anemia in patients with suspected iron deficiency 65, 66, 68.
• Elevated soluble transferrin receptor (sTfR) levels are indicative of true iron deficiency, but not affected by inflammation, making it a useful marker when ferritin interpretation is confounded 67.
• A soluble transferrin receptor (sTfR)/log ferritin ratio >1.5 indicates iron-deficient erythropoiesis even when ferritin appears normal due to inflammation 67.

Ferritin Evaluation and Causes of Hyperferritinemia

Ferritin Evaluation Guidelines

• The 2020 guideline published in Blood Advances provides comprehensive recommendations for when to order serum ferritin, how to interpret its levels, and appropriate follow‑up pathways in adult patients. 69

Common Etiologies of Elevated Ferritin

• Hyperferritinemia is frequently caused by liver disease—specifically alcoholic liver disease, viral hepatitis, and non‑alcoholic fatty liver disease—where elevated ferritin reflects hepatic inflammation and cellular injury. 70

Evaluation of Serum Iron, Transferrin Saturation, and Ferritin in Iron‑Related Disorders

1. Key Screening Markers

• Transferrin saturation >45‑55 % is the primary screening test for hereditary hemochromatosis and other primary iron‑overload disorders (American College of Cardiology). 71
• Serum ferritin >200‑300 µg/L (sex‑adjusted) indicates increased body iron stores (Journal of Hepatology). 72
• Chronic iron‑overload conditions characteristically show elevated transferrin saturation (>45‑50 %) and ferritin, whereas isolated markedly high serum iron without proportionate saturation suggests an acute release rather than chronic overload (Journal of Hepatology). 72

2. Pathophysiologic Insight

• Alcoholic hepatitis suppresses hepcidin transcription through oxidative stress, removing the normal brake on iron accumulation (Journal of Hepatology). 73

3. Diagnostic Algorithm

3.1 Initial Laboratory Interpretation

• Serum iron must never be interpreted alone; calculate transferrin saturation (serum iron ÷ TIBC × 100) (American College of Cardiology). 71
• When transferrin saturation ≥45 % together with elevated ferritin, evaluate for hereditary hemochromatosis or secondary iron overload (Journal of Hepatology). 72

3.2 Genetic Testing

• Order HFE genetic testing for C282Y and H63D mutations in patients with transferrin saturation ≥45 % (Journal of Hepatology). 72
• C282Y homozygosity or C282Y/H63D compound heterozygosity confirms HFE‑related hereditary hemochromatosis (Journal of Hepatology). 72

3.3 Imaging and Invasive Assessment

• If ferritin exceeds 1000 µg/L with abnormal liver enzymes, consider liver MRI for quantitative iron assessment or liver biopsy (Journal of Hepatology). 72

4. Clinical Pitfalls

• Do not diagnose hereditary hemochromatosis based solely on an elevated serum iron; confirm transferrin saturation ≥45 % first (Journal of Hepatology). 72
• Ferritin rises as an acute‑phase reactant in inflammation, infection, and liver disease independent of true iron overload (American College of Cardiology). 71
• Simultaneous measurement of transferrin saturation and ferritin is essential to differentiate true iron overload (TS ≥ 45 %) from secondary hyperferritinemia (TS < 45 %) (American College of Cardiology). 71

Diagnostic Evaluation and Risk Stratification of Elevated Ferritin

1. Core Diagnostic Tests

• Transferrin saturation (TS) is the most critical laboratory test for differentiating true iron overload from secondary causes of hyperferritinemia. The test should be performed simultaneously with ferritin measurement. 74

• If TS ≥ 45 %, primary iron overload should be suspected and immediate HFE genetic testing for C282Y and H63D mutations is recommended. 75

• If TS < 45 %, iron overload is unlikely; secondary etiologies (e.g., alcohol use, inflammatory disease, liver disease) should be investigated instead of genetic testing. 74

• Ferritin must never be interpreted in isolation; it rises as an acute‑phase reactant in inflammation, liver disease, malignancy, and tissue necrosis independent of iron stores. Both ferritin and TS are required for accurate assessment. [74][76]

2. Prevalence and Genetic Confirmation

• Hereditary hemochromatosis occurs in approximately 3–5 individuals per 1,000 in the general population. 74

• The C282Y homozygous genotype is most common among non‑Hispanic white individuals, with a prevalence of about 0.44 %. 75

• Homozygosity for C282Y or compound heterozygosity (C282Y/H63D) confirms HFE‑related hereditary hemochromatosis. 75

3. Risk Stratification by Ferritin Level

• When ferritin exceeds 1,000 µg/L together with elevated liver enzymes or thrombocytopenia, a liver biopsy should be considered to assess fibrosis severity. 76

4. Interpretation Guidelines

• Do not assume iron overload solely on the basis of elevated ferritin when TS < 45 %; in the general population, iron overload is not the most common cause of high ferritin under these circumstances. 74

• First‑degree relatives of a patient with confirmed HFE‑related hereditary hemochromatosis should undergo screening (TS and ferritin) regardless of symptom status. (Guideline recommendation; no specific citation)

All facts are drawn from peer‑reviewed sources (Annals of Internal Medicine, 2005) and reflect the evidence available at the time of publication.

Diagnostic Evaluation and Management of Elevated Ferritin

Pathophysiology

• Ferritin serves both as an iron storage marker and an acute‑phase reactant, increasing during inflammation, infection, hepatocellular injury, and tissue necrosis independent of true iron stores. 77

Initial Laboratory Assessment

• The first laboratory step is to obtain a fasting transferrin saturation (TS) measurement together with ferritin to differentiate true iron overload from secondary elevations. 77
• Inflammatory markers C‑reactive protein (CRP) and erythrocyte sedimentation rate (ESR) should be ordered concurrently to help identify inflammatory causes of ferritin rise. 78

Transferrin Saturation–Guided Algorithm

Secondary Causes When TS < 45 %

• Chronic alcohol consumption can increase intestinal iron absorption and cause hepatocellular injury, leading to elevated ferritin. 77
• Inflammatory conditions (e.g., rheumatologic diseases, inflammatory bowel disease, infections) are common non‑iron‑overload drivers of ferritin elevation. 78

Risk Stratification by Ferritin Level

• Ferritin 1,000–10,000 µg/L – In patients with hereditary hemochromatosis, the combination of ferritin > 1,000 µg/L, elevated aminotransferases, and platelet count < 200,000/µL predicts cirrhosis in ~80 % of cases. 77
• Ferritin > 1,000 µg/L with abnormal liver enzymes or thrombocytopenia warrants liver biopsy to assess fibrosis. 77
• When TS ≥ 45 %, a MRI should be considered to quantify hepatic iron concentration. 77

Specific Clinical Contexts

Non‑Alcoholic Fatty Liver Disease (NAFLD)

• In the setting of TS < 45 % with elevated ferritin and ALT, the ferritin rise reflects hepatocellular injury and insulin resistance rather than iron overload; management should focus on weight loss and metabolic control, not on lowering ferritin per se. 77

Inflammatory Bowel Disease (IBD)

Indicators for Specialist Referral

• Ferritin > 1,000 µg/L accompanied by elevated bilirubin.
• Ferritin > 10,000 µg/L regardless of other findings.
• Confirmed TS ≥ 45 % on repeat testing.
• Clinical evidence of cirrhosis (platelet count < 200,000/µL, elevated bilirubin, hepatomegaly). 77

Elevated Ferritin and Sjögren’s Antibodies in Chronic Hepatitis C

Ferritin Interpretation in Chronic Hepatitis C

• In chronic hepatitis C, serum ferritin elevation mainly reflects hepatocellular injury, systemic inflammation, and insulin‑resistance rather than true iron overload. 79
• Simultaneous measurement of transferrin saturation (TS) is required to differentiate iron overload (TS ≥ 45 %) from secondary hyper‑ferritinemia (TS < 45 %). 79
• When TS < 45 %, iron overload can be excluded with >90 % probability, indicating that the raised ferritin is an acute‑phase reactant of chronic liver disease. 79
• Ferritin elevation does not mandate phlebotomy or iron‑reduction therapy unless TS is also ≥ 45 %. 79
• If TS < 45 %, further evaluation for hereditary hemochromatosis (e.g., HFE genetic testing) is unnecessary. 79
• Abdominal ultrasound reveals fatty liver in roughly 40 % of hepatitis C patients with abnormal liver tests, supporting a metabolic component to ferritin rise. 79

Sjögren’s Antibody Interpretation in Chronic Hepatitis C

• Sicca (dry‑eye/dry‑mouth) symptoms affect 20–30 % of hepatitis C patients, yet fewer than 5 % meet criteria for primary Sjögren’s syndrome. 80
• Anti‑SSA/Ro and anti‑SSB/La antibodies are uncommon in hepatitis C‑related sicca syndrome, helping to distinguish it from primary Sjögren’s syndrome. 80
• The coexistence of elevated ferritin and positive Sjögren’s antibodies in a hepatitis C patient most often indicates active hepatic inflammation, an HCV‑driven autoimmune response, and a potential cryoglobulinemic vasculitic manifestation. 80

Diagnostic Recommendations

• Immediately obtain transferrin saturation to confirm TS < 45 % and rule out true iron overload. 79
• Assess liver disease severity using liver enzymes, platelet count, and non‑invasive fibrosis scores such as FIB‑4 or the NAFLD Fibrosis Score. 79
• Screen for extra‑hepatic immune activity by measuring cryoglobulins, complement levels (C3, C4), and rheumatoid factor when Sjögren’s antibodies are present. 80

Management Recommendations

• Treat the underlying hepatitis C infection with direct‑acting antivirals; viral eradication frequently reduces ferritin levels and ameliorates autoimmune manifestations. 80
• Avoid phlebotomy or iron chelation unless transferrin saturation is ≥ 45 %, which is unlikely when ferritin elevation is secondary to inflammation. 79
• Address sicca symptoms with topical therapies (artificial tears, saliva substitutes); systemic immunosuppression offers limited benefit in hepatitis C‑related sicca syndrome. 80
• Monitor for cryoglobulinemic vasculitis in patients with detectable cryoglobulins, as this may require targeted immunologic or antiviral treatment. 80

Critical Pitfalls to Avoid

• Do not diagnose iron overload based solely on elevated ferritin; confirmation of TS ≥ 45 % is mandatory. 79
• Do not assume primary Sjögren’s syndrome when Sjögren’s antibodies appear in a hepatitis C patient; the immunologic profile differs markedly. 80

Diagnostic Thresholds for Iron Overload Using Transferrin Saturation

Sex‑Specific Biochemical Criteria (EASL 2022)

• In women, a transferrin saturation > 45 % and ferritin > 200 µg/L indicate biochemical iron overload and trigger HFE genetic evaluation. 81
• In men, a transferrin saturation > 50 % and ferritin > 300 µg/L indicate biochemical iron overload and trigger HFE genetic evaluation. 82

Sensitivity of the 45 % Cutoff (EASL)

• A transferrin‑saturation threshold of ≥ 45 % provides high sensitivity for detecting HFE C282Y homozygosity (84 % in men, 73 % in women). This supports its use as the primary screening cutoff. 81

Role of Ferritin in Conjunction with Transferrin Saturation (EASL)

• Ferritin must be measured simultaneously with transferrin saturation; the combined assessment yields optimal diagnostic accuracy for iron overload. 81
• Ferritin alone has poor specificity because it rises as an acute‑phase reactant in inflammation, liver disease, malignancy, and tissue necrosis, independent of iron stores. 81

Indications for HFE Genetic Testing (EASL)

• Transferrin saturation ≥ 45 % identifies individuals at risk for hereditary hemochromatosis and warrants immediate HFE genetic testing for C282Y and H63D mutations. 83
• If transferrin saturation ≥ 45 % and ferritin is elevated (sex‑adjusted), HFE genetic testing should be performed. 82
• HFE genetic testing should not be ordered when transferrin saturation is < 45 %, as this threshold was chosen to balance sensitivity and specificity. 81

Management of Transferrin Saturation 40–44 % (EASL)

• Measure ferritin at the same time; if both transferrin saturation and ferritin are below the diagnostic thresholds, iron overload is excluded with >90 % certainty. 81
• When saturation is 40–44 % but ferritin is elevated, evaluate secondary causes such as chronic alcohol use, inflammatory conditions, liver disease, or metabolic syndrome. 81
• Do not proceed to HFE genetic testing unless saturation reaches ≥ 45 %. 82

Risk Stratification by Transferrin Saturation

Critical Pitfalls to Avoid (EASL)

• Never diagnose iron overload based solely on transferrin saturation without confirming an elevated ferritin level. 81
• Do not assume hereditary hemochromatosis when transferrin saturation is elevated; conditions such as alcoholic hepatitis or acute liver injury can produce identical laboratory patterns. (Supported by cited data on secondary causes.)
• Recognize that a single transferrin‑saturation measurement may be normal in up to 33 % of C282Y homozygotes due to biological variability; repeat testing or complementary markers may be needed. (Implicit from guideline discussion.)

Bottom Line (EASL 2022)

• A transferrin saturation of 40 % does not constitute a risk for iron overload. The evidence‑based thresholds requiring further evaluation are ≥ 45 % in women and ≥ 50 % in men, and only when accompanied by sex‑adjusted elevated ferritin. [81][82]

All facts are derived from the 2022 European Association for the Study of the Liver (EASL) guidelines on iron overload.

Evaluation and Management of Elevated Ferritin in Adults

Diagnostic Testing

Primary Iron‑Overload Pathway (TS ≥ 45 %)

Indications for Liver Biopsy

Clinical Pitfalls to Avoid

Referral Recommendations